Final report of the French Multicenter Phase II Study of the Nitrosourea Fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases

MLA

Jacquillat, C., et al. “Final Report of the French Multicenter Phase II Study of the Nitrosourea Fotemustine in 153 Evaluable Patients with Disseminated Malignant Melanoma Including Patients with Cerebral Metastases.” Cancer, vol. 66, no. 9, Nov. 1990, p. 1873. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.9171950&authtype=sso&custid=ns315887.

APA

Jacquillat, C., Khayat, D., Banzet, P., Weil, M., Fumoleau, P., Avril, M.-F., Namer, M., Bonneterre, J., Kerbrat, P., Bonerandi, J. J., Bugat, R., Montcuquet, P., Cupissol, D., Lauvin, R., Vilmer, C., Prache, C., & Bizzari, J. P. (1990, November 1). Final report of the French Multicenter Phase II Study of the Nitrosourea Fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases. Cancer, 66(9), 1873.

Chicago

Jacquillat, C., D. Khayat, P. Banzet, M. Weil, P. Fumoleau, M.-F. Avril, M. Namer, et al. 1990. “Final Report of the French Multicenter Phase II Study of the Nitrosourea Fotemustine in 153 Evaluable Patients with Disseminated Malignant Melanoma Including Patients with Cerebral Metastases.” Cancer, November 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.9171950&authtype=sso&custid=ns315887.